Top-Accessed Article: UV Light Tanning as a Type of Substance-Related Disorder

2002;288(18):2282-2292. 3. Perry JK, Emerald BS, Mertani HC, Lobie PE. The oncogenic potential of growth hormone. Growth Horm IGF Res. 2006;16(5-6):277-289. 4. Anderson NG. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem J. 1992;284(pt 3):649-652. 5. Argetsinger LS, Campbell GS, Yang X, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 1993;74(2):237-244. 6. Molhoek KR, Shada AL, Smolkin M, et al. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R. Melanoma Res. 2011;21(4):274-284. 7. Capoluongo E. Insulin-like growth factor system and sporadic malignant melanoma. Am J Pathol. 2011;178(1):26-31. 8. Yajima I, Kumasaka MY, Thang ND, et al. RAS/RAF/MEK/ERK and PI3K/PTEN/ AKT signaling in malignant melanoma progression and therapy. Dermatol Res Pract. 2012;2012:354191. 9. Caldarola G, Battista C, Pellicano R. Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. Clin Ther. 2010;32(1):57-59. 10. Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol. 2009;20(2):358-364. 11. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84(4):1155-1228. 12. Bourguignon JP, Piérard GE, Ernould C, et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet. 1993;341(8859):1505-1506. 13. Piérard GE, Piérard-Franchimont C, Nikkels A, Nikkels-Tassoudji N, Arrese JE, Bourguignon JP. Naevocyte triggering by recombinant human growth hormone. J Pathol. 1996;180(1):74-79. 14. Bozzola E, Giacchero R, Barberi S, Borroni G. Sutton’s nevus and growth hormone therapy. Minerva Pediatr. 2004;56(3):349-351. 15. Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol. 1997;137(4):545-548. 16. Wyatt D. Melanocytic nevi in children treated with growth hormone. Pediatrics. 1999;104(4, pt 2):1045-1050. 17. Lincoln DT, Sinowatz F, Kölle S, Takahashi H, Parsons P, Waters M. Upregulation of growth hormone receptor immunoreactivity in human melanoma. Anticancer Res. 1999;19(3A):1919-1931. 18. Fleming MG, Howe SF, Graf LH Jr. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas. Am J Dermatopathol. 1994;16(4):383-391. 19. Tavakkol A, Elder JT, Griffiths CE, et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol. 1992;99(3):343-349. 20. Chatelain P, Naville D, Avallet O, et al. Paracrine and autocrine regulation of insulinlike growth factor I. Acta Paediatr Scand Suppl. 1991;372:92-96. 21. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW, Koprowsk H. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer. 1987;40(5):687-690. 22. Satyamoorthy K, Li G, Vaidya B, Kalabis J, Herlyn M. Insulin-like growth factorI-induced migration of melanoma cells is mediated by interleukin-8 induction. Cell Growth Differ. 2002;13(2):87-93. 23. Kanter-Lewensohn L, Dricu A, Girnita L, Wejde J, Larsson O. Expression of insulinlike growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: a potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins. Growth Factors. 2000;17(3):193-202. 24. Ginarte M, Garcı́a-Caballero T, Fernández-Redondo V, Beiras A, Toribio J. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities. J Cutan Pathol. 2000;27(6):276-282. 25. Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A. Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med. 2000; 136(6):476-481. 26. Chatzistamou I, Volakaki AA, Schally AV, Kiaris H, Kittas C. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas. Regul Pept. 2008;147(1-3):33-36.